• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国 1999 年至 2018 年非酒精性脂肪性肝病的流行病学特征。

Epidemiological Features of NAFLD From 1999 to 2018 in China.

机构信息

Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.

Institute of Model Animal of Wuhan University, Wuhan, China.

出版信息

Hepatology. 2020 May;71(5):1851-1864. doi: 10.1002/hep.31150.

DOI:10.1002/hep.31150
PMID:32012320
Abstract

With dramatic changes in lifestyles over the last 20 years, nonalcoholic fatty liver disease (NAFLD) has become the most prevalent liver disorder in China but has not received sufficient attention. NAFLD-related advanced liver disease and its mortality along with its overall disease burden are expected to increase substantially. There is thus an imperative need to clarify the epidemiological features of NAFLD to guide a holistic approach to management. We summarize eight epidemiological features of NAFLD in China over the past two decades using systematic review and meta-analysis methodology. Our data reveal a rapid growth in the NAFLD population, especially among younger individuals. Importantly, there is a strong ethnic difference in body mass index (BMI) and genetic risk of NAFLD compared with the US population. The etiology of advanced liver disease and its complications (e.g., hepatocellular carcinoma) has been altered because of a Westernized lifestyle and the implementation of effective vaccination strategies against viral hepatitis. Regional epidemiological patterns of NAFLD indicate that economics, environment, and lifestyle are critical factors in disease progression. The analysis also indicates that a large number of patients remain undiagnosed and untreated because of the inadequacy of diagnostic tools and the absence of effective pharmacologic therapies. Given the burden of NAFLD, future policy and research efforts need to address knowledge gaps to mitigate the risk burden.

摘要

在过去的 20 年中,生活方式发生了巨大变化,非酒精性脂肪性肝病(NAFLD)已成为中国最常见的肝脏疾病,但尚未得到足够重视。NAFLD 相关的晚期肝病及其死亡率以及整体疾病负担预计将大幅增加。因此,迫切需要阐明 NAFLD 的流行病学特征,以指导整体管理方法。我们使用系统评价和荟萃分析方法总结了过去 20 年中国 NAFLD 的八个流行病学特征。我们的数据显示,NAFLD 人群,尤其是年轻人,呈快速增长趋势。重要的是,与美国人群相比,NAFLD 的体重指数(BMI)和遗传风险存在明显的种族差异。由于西方化的生活方式和有效的病毒性肝炎疫苗接种策略的实施,晚期肝病及其并发症(如肝细胞癌)的病因已经发生改变。NAFLD 的区域性流行病学模式表明,经济、环境和生活方式是疾病进展的关键因素。分析还表明,由于诊断工具不足和缺乏有效的药物治疗,大量患者未被诊断和治疗。鉴于 NAFLD 的负担,未来的政策和研究工作需要解决知识差距,以减轻风险负担。

相似文献

1
Epidemiological Features of NAFLD From 1999 to 2018 in China.中国 1999 年至 2018 年非酒精性脂肪性肝病的流行病学特征。
Hepatology. 2020 May;71(5):1851-1864. doi: 10.1002/hep.31150.
2
Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis.2008 年至 2018 年中国非酒精性脂肪性肝病负担的意外快速增长:系统评价和荟萃分析。
Hepatology. 2019 Oct;70(4):1119-1133. doi: 10.1002/hep.30702.
3
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.建立中国、法国、德国、意大利、日本、西班牙、英国和美国 2016-2030 年非酒精性脂肪性肝病疾病负担模型。
J Hepatol. 2018 Oct;69(4):896-904. doi: 10.1016/j.jhep.2018.05.036. Epub 2018 Jun 8.
4
Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study.2019-2030 年加拿大非酒精性脂肪性肝病负担:建模研究。
CMAJ Open. 2020 Jun 9;8(2):E429-E436. doi: 10.9778/cmajo.20190212. Print 2020 Apr-Jun.
5
Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的流行病学与自然史
Semin Liver Dis. 2015 Aug;35(3):221-35. doi: 10.1055/s-0035-1562943. Epub 2015 Sep 17.
6
[Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].[非酒精性脂肪性肝病/非酒精性脂肪性肝炎管理概述]
Yakugaku Zasshi. 2019;139(9):1147-1153. doi: 10.1248/yakushi.19-00011-1.
7
Nonalcoholic fatty liver disease burden: Australia, 2019-2030.非酒精性脂肪性肝病负担:澳大利亚,2019-2030 年。
J Gastroenterol Hepatol. 2020 Sep;35(9):1628-1635. doi: 10.1111/jgh.15009. Epub 2020 Feb 26.
8
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.对非酒精性脂肪性肝病流行情况的建模显示,疾病负担呈指数级增长。
Hepatology. 2018 Jan;67(1):123-133. doi: 10.1002/hep.29466. Epub 2017 Dec 1.
9
Nonalcoholic fatty liver disease: Evolving paradigms.非酒精性脂肪性肝病:不断变化的范式。
World J Gastroenterol. 2017 Sep 28;23(36):6571-6592. doi: 10.3748/wjg.v23.i36.6571.
10
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.2020年非酒精性脂肪性肝病:疾病现状
Gastroenterology. 2020 May;158(7):1851-1864. doi: 10.1053/j.gastro.2020.01.052. Epub 2020 Feb 13.

引用本文的文献

1
Association of pan-immune-inflammation value and atherogenic index of plasma with chronic coronary syndrome in non-alcoholic fatty liver disease patients.非酒精性脂肪性肝病患者中全免疫炎症值和血浆致动脉粥样硬化指数与慢性冠状动脉综合征的关联
Front Endocrinol (Lausanne). 2025 Aug 29;16:1650319. doi: 10.3389/fendo.2025.1650319. eCollection 2025.
2
Causal association between macrophage migration inhibitory factor and nonalcoholic fatty liver disease: A two-sample Mendelian randomization study.巨噬细胞移动抑制因子与非酒精性脂肪性肝病之间的因果关联:一项两样本孟德尔随机化研究。
Medicine (Baltimore). 2025 Sep 5;104(36):e44106. doi: 10.1097/MD.0000000000044106.
3
Risk factors of metabolic dysfunction-associated fatty liver disease in Chinese nurses: an ambispective cohort study.
中国护士代谢功能障碍相关脂肪性肝病的危险因素:一项双向队列研究。
Front Public Health. 2025 Aug 20;13:1554793. doi: 10.3389/fpubh.2025.1554793. eCollection 2025.
4
Metabolic and hepatic biomarkers associated with MASLD in the Chinese population.中国人群中与代谢相关脂肪性肝病(MASLD)相关的代谢和肝脏生物标志物。
Sci Rep. 2025 Aug 27;15(1):31593. doi: 10.1038/s41598-025-17219-3.
5
Trends in the prevalence of steatotic liver disease among Chinese adults, 2015-2023: A nationwide cross-sectional study.2015 - 2023年中国成年人脂肪性肝病患病率趋势:一项全国性横断面研究
Hepatol Commun. 2025 Aug 26;9(9). doi: 10.1097/HC9.0000000000000785. eCollection 2025 Sep 1.
6
Role of prokineticins and T-reg cells in obesity-associated metabolic oxidative dysregulation in NAFLD.前动力蛋白和调节性T细胞在非酒精性脂肪性肝病中肥胖相关代谢性氧化失调中的作用。
Sci Rep. 2025 Aug 12;15(1):29470. doi: 10.1038/s41598-025-97969-2.
7
Molecular mechanisms of dose-dependent regulation of hepatic lipid metabolism by BaP through modulation of AhR binding to XRE1 or XRE3.苯并[a]芘通过调节芳烃受体与XRE1或XRE3的结合对肝脏脂质代谢进行剂量依赖性调控的分子机制。
Front Pharmacol. 2025 Jul 25;16:1595566. doi: 10.3389/fphar.2025.1595566. eCollection 2025.
8
Pachymaran alleviates fat accumulation, hepatocyte degeneration, and injury in mice with nonalcoholic fatty liver disease.茯苓聚糖可减轻非酒精性脂肪性肝病小鼠的脂肪堆积、肝细胞变性和损伤。
Open Med (Wars). 2025 Jul 24;20(1):20251241. doi: 10.1515/med-2025-1241. eCollection 2025.
9
Advances in diagnostic ultrasound techniques for assessing liver steatosis in nonalcoholic fatty liver disease.用于评估非酒精性脂肪性肝病中肝脏脂肪变性的诊断超声技术进展。
ILIVER. 2023 Nov 3;2(4):214-218. doi: 10.1016/j.iliver.2023.10.002. eCollection 2023 Dec.
10
Overweight and infection: a correlation in metabolic dysfunction-associated fatty liver disease.超重与感染:代谢功能障碍相关脂肪性肝病中的一种关联
Front Cell Infect Microbiol. 2025 Jun 18;15:1565298. doi: 10.3389/fcimb.2025.1565298. eCollection 2025.